XML 75 R66.htm IDEA: XBRL DOCUMENT v3.22.2
Business Combinations - Summary of Unaudited Pro Forma Financial Information (Details) - Inform Diagnostics - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Business Acquisition [Line Items]        
Revenue $ 133,720 $ 193,156 $ 486,027 $ 589,851
Net income attributable to Fulgent $ 10,461 $ 83,271 $ 162,317 $ 282,703
Basic earnings per common share attributable to Fulgent $ 0.34 $ 2.86 $ 5.36 $ 9.75
Diluted earnings per common share attributable to Fulgent $ 0.34 $ 2.70 $ 5.20 $ 9.18